PMID- 17702902 OWN - NLM STAT- MEDLINE DCOM- 20071206 LR - 20131121 IS - 0022-3565 (Print) IS - 0022-3565 (Linking) VI - 323 IP - 2 DP - 2007 Nov TI - 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. PG - 477-87 AB - The popular drug of abuse 3,4-methylenedioxymethamphetamine (MDMA) has complex interactions with thermoregulatory systems, resulting in either hyperthermia or hypothermia. MDMA induces hypothermia when given to animals housed at a low ambient temperature. In this study we report that MDMA (7.5 mg/kg i.p.) given at normal ambient temperatures of 24 to 25 degrees C caused, in conscious freely moving rats, hypothermia (mean decrease from baseline of 1.1 +/- 0.06 degrees C at 40 min). Pretreating animals with a 0.5 mg/kg i.p. dose of the 5-hydroxytryptamine 1A (5-HT(1A)) antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide (WAY 100635) not only prevented MDMA-induced hypothermia, but resulted in the development of hyperthermia (mean temperature increase from baseline of 0.74 +/- 0.2 degrees C at 120 min). After treatment with WAY 100635, MDMA also elicited an enhanced tachycardia (mean increases in heart rate from baseline of 110 +/- 16 beats/min at 90 min). To identify the location of 5-HT(1A) receptors responsible for hypothermia induced by MDMA, we first investigated the role of 5-HT(1A) receptors in the rostral raphe pallidus (rRP) in decreases in temperature evoked by the known 5-HT(1A) agonist 8-hydroxy-2-di-n-propylamino-tetralin (DPAT). Microinjections of 0.5 nmol of WAY 100635 into the rRP significantly attenuated DPAT (0.2 mg/kg i.p.)-elicited hypothermia. In parallel experiments, we found that microinjections of WAY 100635 into the rRP, while significantly augmenting MDMA-mediated tachycardia, did not alter body temperature. These results demonstrate that although hypothermia mediated by both MDMA and DPAT shares a common dependence on the activation of 5-HT(1A) receptors, the location of these receptors is different for each drug. FAU - Rusyniak, Daniel E AU - Rusyniak DE AD - Departments of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. drusynia@iupui.edu FAU - Zaretskaia, Maria V AU - Zaretskaia MV FAU - Zaretsky, Dmitry V AU - Zaretsky DV FAU - DiMicco, Joseph A AU - DiMicco JA LA - eng GR - DA20484/DA/NIDA NIH HHS/United States GR - NS19883/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20070816 PL - United States TA - J Pharmacol Exp Ther JT - The Journal of pharmacology and experimental therapeutics JID - 0376362 RN - 0 (Piperazines) RN - 0 (Pyridines) RN - 112692-38-3 (Receptor, Serotonin, 5-HT1A) RN - 71IH826FEG (N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide) RN - 78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - 8-Hydroxy-2-(di-n-propylamino)tetralin/analysis/*pharmacology MH - Animals MH - Blood Pressure/drug effects MH - Body Temperature/*drug effects MH - Dose-Response Relationship, Drug MH - Heart Rate/drug effects MH - Male MH - Motor Activity/drug effects MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - Piperazines/pharmacology MH - Pyridines/pharmacology MH - Raphe Nuclei/drug effects/physiology MH - Rats MH - Rats, Sprague-Dawley MH - Receptor, Serotonin, 5-HT1A/*physiology EDAT- 2007/08/19 09:00 MHDA- 2007/12/07 09:00 CRDT- 2007/08/19 09:00 PHST- 2007/08/19 09:00 [pubmed] PHST- 2007/12/07 09:00 [medline] PHST- 2007/08/19 09:00 [entrez] AID - jpet.107.126169 [pii] AID - 10.1124/jpet.107.126169 [doi] PST - ppublish SO - J Pharmacol Exp Ther. 2007 Nov;323(2):477-87. doi: 10.1124/jpet.107.126169. Epub 2007 Aug 16.